AstraZeneca : BioPharmaceuticals presentation
BioPharmaceuticals Ruud Dobber, EVP and President, BioPharmaceuticals Sharon Barr, EVP, BioPharmaceuticals R&D ...
Amolyt Pharma Securities Litigation Reform Act Financial Ambition Statements Clinical Trials Appendix Ambition Statements Total Revenue
Source: marketscreener.com